Early detection of tumors may be a key to saving vision
Philadelphia-Early detection and treatment of retinoblastoma are key to preserving vision, noted Jerry A. Shields, director, Oncology Service, Wills Eye Hospital, and professor of ophthalmology, Thomas Jefferson University, Philadelphia.
Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.